NAUTILUS BIOTECHNOLOGY INC.
-
USD
(-)
- 15 min delayed data - NASDAQ Stocks
| Open: | - |
| Change: | - |
| Volume: | - |
| Low: | - |
| High: | - |
| High / Low range: | - |
| Type: | Stocks |
| Ticker: | NAUT |
| ISIN: |
NAUTILUS BIOTECHNOLOGY INC. news, videos and press releases
For more news please use our advanced search feature.
NAUTILUS BIOTECHNOLOGY INC. - More news...
NAUTILUS BIOTECHNOLOGY INC. - More news...
- 02/27/2025 - 13:00 Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results
- 02/18/2025 - 13:00 Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference
- 02/06/2025 - 13:00 Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
- 10/31/2024 - 12:00 Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
- 10/30/2024 - 12:00 Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
- 10/29/2024 - 12:00 Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
- 10/08/2024 - 12:00 Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024
- 09/17/2024 - 12:00 Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer
- 08/14/2024 - 12:00 Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- 07/30/2024 - 12:00 Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
- 07/09/2024 - 12:00 Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
- 05/23/2024 - 12:00 Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- 04/30/2024 - 12:00 Nautilus Biotechnology Reports First Quarter 2024 Financial Results
- 04/11/2024 - 12:00 Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
- 02/28/2024 - 13:00 Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- 02/22/2024 - 13:00 Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
- 02/07/2024 - 13:00 Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
- 11/30/2023 - 13:00 Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
- 11/01/2023 - 12:05 Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
- 10/31/2023 - 12:05 Nautilus Biotechnology Reports Third Quarter 2023 Financial Results
- 10/11/2023 - 12:05 Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
- 09/06/2023 - 11:30 Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
- 08/04/2023 - 12:00 Nautilus Biotechnology to Participate in Upcoming August Investor Conferences
- 08/02/2023 - 11:30 Nautilus Biotechnology Reports Second Quarter 2023 Financial Results
- 07/11/2023 - 13:23 Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023
- 05/24/2023 - 12:05 Nautilus Biotechnology to Participate in Upcoming June Investor Conferences
- 05/02/2023 - 10:30 Nautilus Biotechnology Reports First Quarter 2023 Financial Results
- 04/18/2023 - 20:05 Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023
- 03/23/2023 - 12:00 Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
- 03/07/2023 - 13:00 Nautilus Biotechnology Announces “First Access Challenge” Winners
